Postmenopausal Early Cognitive Dysfunction
Conditions
Interventions
drug control group:Donepezil tablets 10mg/time orally once daily
Traditional Chinese Medicine Treatment Group:Oral Tranquilizer Mixture, 30ml three times a day
Sponsors
Shanghai Seventh People's Hospital
Eligibility
Sex/Gender
Female
Age
40 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) women >40 years of age; (2) those who met the diagnostic criteria for MCI early postmenopause and the criteria for identification of cardio-renal dysfunction type; and (3) those who agreed to sign an informed consent form volunteered and were able to participate in tests of neuropsychological mobility and other tests.
Exclusion criteria
Exclusion criteria: (1) History of psychiatric disorders (e.g. dissociative disorders obsessive-compulsive disorder personality disorders schizophrenia bipolar disorder major depressive disorder anxiety disorders etc.); (2) Those with a clear history of previous cerebrovascular stroke head trauma make etc. causing cognitive impairment; (3) Those with a history of drug or alcohol dependence or allergy to the study medication; (4) Those taking cognitive-improving antipsychotic medications; ( (5) Participants who are taking other clinical trial medications or are in a washout period after stopping the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chinese Medicine Points Scale;Montreal Cognitive Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Improved Kupperman Rating;Activities of Daily Living Scale (ADL); | — |
Countries
CHINA
Contacts
Public ContactZhangxiaodan
The Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine
Outcome results
None listed